Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q2 2025 · 10-Q
Revenue$217.09M$217.09M+10.8% vs Q2 2024 Net Income-$3.59M-$3.59MN/M vs Q2 2024 EPS Diluted-$0.12-$0.12N/M vs Q2 2024 Gross Profit$182,414,000+9.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,684,000N/M Free Cash Flowderived-$6,313,000N/M Margins · derivedGross margin84.0%−0.7 pt vs Q2 2024
Operating margin-1.5%−4.1 pt vs Q2 2024
Net margin-1.7%−6.7 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 4, 2025 · 35 d after period end